BJUI compassPub Date : 2026-11-13eCollection Date: 2026-11-01DOI: 10.1002/bco2.70304
Christian Thomas, Mandy Ehrt, Benedikt Hoeh, Mario Hallaschek, Katharina Sonntag, Maximilian Winkelkotte, Emma Peklo, Martin Baunacke
{"title":"Expectations of and willingness to pay for robotic-assisted surgery: A prospective analysis before and after live presentation to the public.","authors":"Christian Thomas, Mandy Ehrt, Benedikt Hoeh, Mario Hallaschek, Katharina Sonntag, Maximilian Winkelkotte, Emma Peklo, Martin Baunacke","doi":"10.1002/bco2.70304","DOIUrl":"10.1002/bco2.70304","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the expectation of and copayment willingness for robotic-assisted surgery (RAS) within a German cohort.</p><p><strong>Patients and methods: </strong>A cross-sectional survey at a university hospital's open house gathered responses from 273 participants before and after RAS exhibition. The questionnaire assessed demographics, pre-existing knowledge about and expectation of RAS as well as copayment willingness before and after live presentation of a multiport system. Statistical analyses, including Wilcoxon test, comparison of proportions test and multivariate logistic regression, identified key associations.</p><p><strong>Results: </strong>54.1% of participants assumed that RAS offers some advantages but is not additionally reimbursed. Confidence in robotic surgery significantly increased (<i>p</i> = 0.004) after RAS exhibition. Additionally, there was a significant shift (<i>p</i> < 0.0001) to accept postponement of surgery for RAS. Regarding copayment willingness, the median amount was €500 (95% confidence interval [95% CI] €0-3 000) before and €1 000 (95% CI €0-10 000) after RAS exhibition. Higher age (odds ratio 2.18; <i>p</i> = 0.0079) and net income >€2 500 were the only independent predictors for copayment amounts ≥€1 000.</p><p><strong>Conclusion: </strong>This study reveals that enabling the public to gain insight into RAS might lead to a better understanding of both the advances and limitations of this modern technology. In principle, the public accepts within limits postponement of surgery to receive RAS. To a certain extent, there is also a willingness for copayment to receive RAS, but the risk of persuasion by presenting innovative minimally invasive surgical approaches must be carefully taken into account.</p>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"7 11","pages":"e70304"},"PeriodicalIF":2.0,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13768203/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149413570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJUI compassPub Date : 2026-11-06DOI: 10.1002/bco2.70299
Kenneth A. McLean, Ellen Gardner, Kathryn Kirkwood, CJ Shukla, Alexander Laird, James P. Blackmur
{"title":"Routine foreskin pathology in adults: Low yield, high cost—Time to change practice?","authors":"Kenneth A. McLean, Ellen Gardner, Kathryn Kirkwood, CJ Shukla, Alexander Laird, James P. Blackmur","doi":"10.1002/bco2.70299","DOIUrl":"https://doi.org/10.1002/bco2.70299","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This study aimed to determine the diagnostic yield for malignant lesions and cost-effectiveness of routine foreskin pathology in adults.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Subjects/Patients and Methods</h3>\u0000 \u0000 <p>A retrospective audit was conducted of all adult circumcisions (age ≥16) performed between January 2015 and February 2025 at a UK tertiary centre. Clinical and pathology records were reviewed to identify unexpected cancer diagnoses—defined as cases with no prior biopsy evidence or clinical suspicion. The number needed to screen (NNS) to detect one cancer was calculated, and pathology costs were estimated based on local processing costs and the pathologist workload score for each sample.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There were 2503 adult circumcisions performed between 2015 and 2025, with 2.6% (<i>n</i> = 66/2503) cancers detected on pathological assessment. Of these, 78.8% (<i>n</i> = 52/66) patients with confirmed penile cancer had clinically suspicious findings pre-operatively. Therefore, the NNS on routine pathology for unexpected cancers was 109.4 (95% CI = 65.4–183.4), and only one clinically significant cancer (7.1%, <i>n</i> = 1/14 [0.04% overall cohort]) required further treatment (topical ablation). The diagnostic yield was also age-dependent, with low diagnostic yields in patients below age 40 with potentially suspicious pathology (NNS = 178.5, 95% CI: 49.5–650.3). Pathology-associated costs were estimated at £65 584 over the study period (£994 per cancer identified). Targeting pathology to men aged ≥40 with clinical suspicion of cancer would reduce costs by 73.3% (£48 074), while reducing the cost per cancer detected to £350.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Routine foreskin pathology after adult circumcision has a low diagnostic yield for unexpected malignancy and rarely alters management. Targeting pathology to higher yield patient groups may optimise resource use, aligning with national guidelines and delivering substantial cost savings.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"7 11","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.70299","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149356275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJUI compassPub Date : 2026-11-02DOI: 10.1002/bco2.70301
Dinesh K. Agarwal
{"title":"Pelvic sleeve pyeloplasty in adults: A technical refinement of Anderson–Hynes dismembered pyeloplasty","authors":"Dinesh K. Agarwal","doi":"10.1002/bco2.70301","DOIUrl":"https://doi.org/10.1002/bco2.70301","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To describe pelvic sleeve pyeloplasty, a technical refinement of Anderson–Hynes dismembered pyeloplasty for adult ureteropelvic junction obstruction, and to report perioperative and functional outcomes in an initial adult series.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Between 2009 and 2018, 12 adult patients with symptomatic ureteropelvic junction obstruction underwent pelvic sleeve pyeloplasty using a transperitoneal laparoscopic or robot-assisted approach. Preoperative evaluation included computed tomography intravenous pyelography and diuretic Tc-99m MAG3 renography. Patients with previous failed ureteropelvic junction surgery were excluded. The technique preserves and incorporates a sleeve of renal pelvic tissue into the reconstruction to create a broad, continuous, tension-free ureteropelvic anastomosis while minimizing manipulation of healthy ureteric tissue.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>All procedures were completed successfully without conversion to open surgery. Eight patients underwent laparoscopic and four underwent robot-assisted pyeloplasty. Mean operative time was 185 min (range 160–255 min), and estimated blood loss ranged from 90 to 350 mL. One patient had intraoperative bleeding from a gonadal vein injury, controlled without transfusion. One patient developed a transient postoperative febrile episode (Clavien–Dindo grade II). No patient developed urinary leakage or required secondary intervention. At a mean follow-up of 38 months (range 24–50 months), all patients were asymptomatic and diuretic Tc-99m MAG3 renography demonstrated unobstructed drainage.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Pelvic sleeve pyeloplasty is a feasible modification of dismembered pyeloplasty that preserves ureteric length, minimizes ureteric manipulation and facilitates a wide, continuous, tension-free ureteropelvic anastomosis. Larger comparative studies are required to validate reproducibility and long-term efficacy.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"7 11","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.70301","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149310857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJUI compassPub Date : 2026-10-30DOI: 10.1002/bco2.70294
Gregory Harrison, Bogdan Toia, Anju Sahdev, Prabhakar Rajan, Benjamin W. Lamb
{"title":"The impact of 5-alpha reductase inhibitors on multiparametric MRI diagnostic performance and prostate-specific antigen density triage: A systematic review","authors":"Gregory Harrison, Bogdan Toia, Anju Sahdev, Prabhakar Rajan, Benjamin W. Lamb","doi":"10.1002/bco2.70294","DOIUrl":"https://doi.org/10.1002/bco2.70294","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To evaluate the impact of 5-alpha reductase inhibitor (5-ARI) exposure on multiparametric MRI (mpMRI) diagnostic performance for clinically significant prostate cancer (csPCa) and to assess whether standard prostate-specific antigen density (PSAD)-gated biopsy thresholds remain safe in this population.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Subjects/patients and methods</h3>\u0000 \u0000 <p>A systematic review followed PRISMA 2020 (PROSPERO: CRD420251050507). PubMed/MEDLINE, EMBASE and the Cochrane Library were searched from January 2015 to December 2024. Eligible studies reported PI-RADS, PSAD or lesion-level apparent diffusion coefficient (ADC) data by exposure status, biopsy-verified csPCa (ISUP grade group ≥2) and an unexposed comparator (≥100 patients). Risk of bias was assessed using QUADAS-2 and ROBINS-I; heterogeneity precluded meta-analysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Seven comparative studies met inclusion criteria. Patient-level csPCa diagnostic accuracy was largely maintained: Sensitivity at a PI-RADS ≥3 threshold was 93.8% in exposed versus 96.1% in unexposed men, csPCa detection was 39.1% versus 39.3% (p = 0.9), and 5-ARI exposure was not an independent negative predictor of detection. On blinded matched review, peripheral zone lesion ADC was higher in exposed men (869 vs. 765 mm<sup>2</sup>/s, p = 0.04) with lower conspicuity (1.59 vs. 1.78, p = 0.03); that cohort also reported lower adjusted per-lesion yield (OR 0.32, 95% CI 0.18–0.57), confined to the peripheral zone. A PSAD threshold of >0.15 ng/ml/cc avoided biopsy in 37.0% of exposed versus 30.3% of unexposed men, with missed csPCa in 12.3% and 11.0%, respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Across seven heterogeneous observational studies, patient-level mpMRI performance for csPCa appears largely preserved in men receiving 5-ARIs, though this lacks pooled support and was not reproduced in the one lesion-level, zone-stratified analysis. Standard PSAD-gated thresholds, evidenced by a single cohort, may perform comparably across populations. Prospective validation is required.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"7 11","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.70294","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149312723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJUI compassPub Date : 2026-10-26DOI: 10.1002/bco2.70302
{"title":"Correction to “Malignancy yield and clinical predictors in radiologically detected adult urachal anomalies: A retrospective cohort study”","authors":"","doi":"10.1002/bco2.70302","DOIUrl":"https://doi.org/10.1002/bco2.70302","url":null,"abstract":"<p>\u0000 <span>Blomqvist, P</span>, <span>Joulha Ian, L</span>, <span>Holmin, E</span>, <span>Abuhasanein, S</span>. <span>Malignancy yield and clinical predictors in radiologically detected adult urachal anomalies: A retrospective cohort study</span>. <i>BJUI Compass.</i> <span>2026</span>; <span>7</span>(<span>10</span>):e70284. https://doi.org/10.1002/bco2.70284\u0000 </p><p>In the article cited above, one of the authors' surnames has been published incorrectly. The author is currently listed as <b>Lala Joulhay Ian</b>, whereas the correct name is <b>Lala Joulha Ian</b>.</p><p>The online version of this article has been corrected accordingly.</p><p>We apologize for this error.</p>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"7 10","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.70302","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149259464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJUI compassPub Date : 2026-10-22DOI: 10.1002/bco2.70300
{"title":"Correction to “Mixed reality applications in percutaneous stone surgery: a systematic review and meta-analysis of stone-free rate and perioperative complications”","authors":"","doi":"10.1002/bco2.70300","DOIUrl":"https://doi.org/10.1002/bco2.70300","url":null,"abstract":"<p>\u0000 <span>Lo, CY-Z</span>, <span>Toscano, F</span>, <span>Ng, JJ</span>, <span>Jingzeng, D</span>, <span>Khandekhar, A</span>, <span>Shah, H</span>, et al. <span>Mixed reality applications in percutaneous stone surgery: A systematic review and meta-analysis of stone-free rate and perioperative complications. <i>BJUI</i></span> <i>Compass.</i> <span>2026</span>; <span>7</span>(<span>9</span>):e70278. https://doi.org/10.1002/bco2.70278\u0000 </p><p>In the originally published article, the author Ubbo Visser was inadvertently omitted from the author list. Ubbo Visser should have been listed as the tenth (second to last) author, between Sarvesh Saini and Jonathan Katz, with the affiliation Department of Computer Science, University of Miami, Coral Gables, Florida, USA.</p><p>The correct author list is as follows:</p><p>Christopher Yong-Zyn Lo, Frida Toscano, John Joson Ng, Du Jingzeng, Archan Khandekar, Hemendra Shah, Robert Marcovich, Julio Ojalvo, Sarvesh Saini, Ubbo Visser, Jonathan Katz.</p><p>The online version of this article has been corrected accordingly.</p><p>We apologize for this error.</p>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"7 10","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.70300","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJUI compassPub Date : 2026-10-20DOI: 10.1002/bco2.70109
Mohamed Abdelkareem, Tawiz Gul, Mohannad Natheef AbuHaweeleh, Humam Emad Rajha, Hamzah Shehadeh, Mohammed Ebrahim, Ibrahim Alnadhari, Osama Abdeljaleel, Abdullah Al-Ansari, Khaled Al-Rumaihi, Khalid Al Jalham, Asad Zeidan, Morshed Salah
{"title":"Ambulatory bilateral same-session vs. unilateral ureteroscopy: A multicentre cohort study","authors":"Mohamed Abdelkareem, Tawiz Gul, Mohannad Natheef AbuHaweeleh, Humam Emad Rajha, Hamzah Shehadeh, Mohammed Ebrahim, Ibrahim Alnadhari, Osama Abdeljaleel, Abdullah Al-Ansari, Khaled Al-Rumaihi, Khalid Al Jalham, Asad Zeidan, Morshed Salah","doi":"10.1002/bco2.70109","DOIUrl":"10.1002/bco2.70109","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To evaluate the safety, efficacy and feasibility of ambulatory bilateral same-session retrograde intrarenal surgery (BSS-RIRS) compared to unilateral RIRS, under a standardized clinical protocol.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patients and Methods</h3>\u0000 \u0000 <p>We conducted a <b>retrospective multicentre cohort study</b> including 202 adult patients who underwent ambulatory bilateral same-session RIRS (BSS-RIRS) or unilateral RIRS between <b>January 1 and December 31, 2024</b>. All included patients had complete perioperative data and postoperative non-contrast CT imaging at 4–6 weeks. Of these, 95 underwent BSS-RIRS and 107 underwent unilateral RIRS. Demographic, clinical and operative variables were analysed. Stone-free status (defined as residual fragments ≤4 mm) and complication rates (within 30 days) were assessed. <b>Multivariable logistic regression</b> was used to adjust for potential confounders.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>BSS-RIRS patients had significantly longer operative times compared to the unilateral group (106.9 vs. 87.3 minutes, p < 0.001) and were more likely to be treated with thulium lasers (73.4% vs. 54.2%, p = 0.003). Preoperative stenting was notably less common in the BSS-RIRS group (39% vs. 65.4%, p < 0.001). Despite these differences, early complication rates remained low and statistically similar between groups (2.1% vs. 3.7%, p = 0.49), with adjusted regression analysis showing a possible non-inferior BSS-RIRS early complication rate (OR 0.36, p = 0.209). Overall stone-free rates were comparable (85.3% vs. 82.3%, p = 0.56). In regression analysis, bilateral RIRS showed increased odds of stone-free status, but this was not statistically supported (adjusted OR 1.62, 95% CI 0.64–4.10, p = 0.309). Grade A stone-free status (0 mm residual) was significantly lower in the bilateral group (72.8% vs. 93.2%, p < 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Ambulatory BSS-RIRS is a safe and effective approach for managing bilateral renal stones, offering comparable overall stone-free rates and complication profiles to unilateral RIRS. Additionally, it provides procedural efficiency and potential cost-effectiveness when applied in appropriately selected cases. Further studies are warranted to refine patient selection criteria and validate long-term outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"7 10","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13681178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149240520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJUI compassPub Date : 2026-10-18DOI: 10.1002/bco2.70287
Avula Aishwarya Rao, Muhammad Shariq Rahemtoola, Hassaan Aziz, Peter Grice, Mohamed Mubarak, Ian Pearce, Theodora Stasinou, Vaibhav Modgil
{"title":"Does orchidopexy for testicular torsion affect long-term fertility parameters in males: A systematic review","authors":"Avula Aishwarya Rao, Muhammad Shariq Rahemtoola, Hassaan Aziz, Peter Grice, Mohamed Mubarak, Ian Pearce, Theodora Stasinou, Vaibhav Modgil","doi":"10.1002/bco2.70287","DOIUrl":"10.1002/bco2.70287","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The aim of this study is to investigate long-term fertility outcomes following orchidopexy performed for testicular torsion.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patients and Methods</h3>\u0000 \u0000 <p>This systematic review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and was registered with the International Prospective Register of Systematic Reviews (PROSPERO: CRD420251152057). A literature search was conducted from June 2025 to October 2025 across Scopus, PubMed, Web of Science and the StarPlus Library (University of Sheffield). Studies reporting on male patients with a history of testicular torsion who underwent orchidopexy were included. Eligible study designs comprised case reports/series, cohort studies, case–control studies and randomised controlled trials. Studies involving cryptorchidism, orchidectomy or no intervention following exploration, as well as systematic reviews, meta-analyses, editorials, book chapters, conference proceedings/posters, reviews and commentaries, were excluded.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Seventeen articles with 324 patients analysed fertility and hormonal outcomes following detorsion with orchidopexy. Primary outcomes were classified as fertility parameters and semen analysis. Reported pregnancy rates were high, ranging from 90.2% to 91.3% with reported time to pregnancy of 6.6 to 8.9 months. Six studies reported semen parameters with sperm count (11.2–235.4 × 10), motility (51.6–67%) and morphology (3.6–28%) generally within reported reference ranges, although substantial variability existed between studies. Secondary outcomes included hormonal analysis and anti-sperm antibody prevalence. Five studies reported hormonal follicle-stimulating hormone (FSH) and luteinising hormone (LH) levels, eight studies reported testosterone levels and two reported inhibin B levels. Anti-sperm antibodies (ASA) were described in two studies, with positive ASA ranging from 20% to 27.2%. The reported follow-up duration across nine studies was 0.12–11.8 years, although none reported fertility outcomes longitudinally.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This review suggests that fertility potential is generally preserved following testicular detorsion with orchidopexy, with the majority of studies reporting favourable semen profiles and pregnancy outcomes. However, the small number of heterogeneous studies and limited long-term data highlight the need for larger, standardised studies to better define the long-term impact of ","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"7 10","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13678274/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149225522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJUI compassPub Date : 2026-10-16DOI: 10.1002/bco2.70289
Sarika Nalagatla, Aqua Asif, Bhargab Ghoshal, Maria Yacoub, Samuel Davis, Maria Bahhadi-Harbo, Abhishek Reekhaye, Manar Malki, Muddassar Hussain, Neil Barber
{"title":"Decision regret after partial nephrectomy for benign small renal masses: The importance of preoperative counselling","authors":"Sarika Nalagatla, Aqua Asif, Bhargab Ghoshal, Maria Yacoub, Samuel Davis, Maria Bahhadi-Harbo, Abhishek Reekhaye, Manar Malki, Muddassar Hussain, Neil Barber","doi":"10.1002/bco2.70289","DOIUrl":"https://doi.org/10.1002/bco2.70289","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This study aimed to evaluate decision regret following robot-assisted laparoscopic partial nephrectomy (RALPN) for benign small renal masses (SRMs) in patients who did not undergo preoperative renal mass biopsy (RMB) and to assess factors associated with regret and satisfaction with treatment decision-making.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patients and Methods</h3>\u0000 \u0000 <p>We conducted a mixed methods study combining retrospective clinical data with prospective patient-reported outcomes at a high-volume renal cancer centre. Patients who underwent RALPN for indeterminate SRMs ≤4 cm between January 2010 and July 2025 without preoperative RMB and were subsequently found to have benign histology were identified from a prospectively maintained renal cancer database. Participants completed a standardised questionnaire incorporating the validated Decision Regret Scale (DRS). Significant regret was defined as DRS ≥ 25. Decision regret was evaluated in relation to patients' recollection of counselling and perceived quality of preoperative information.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 1480 RALPN procedures performed during the study period, 167 patients met the eligibility criteria. Contact was established with 108 patients, of whom 104 agreed to participate and 58 completed the questionnaire. Median age was 66 years, and median tumour size was 30 mm. No Clavien-Dindo Grade ≥III complications occurred. Most patients recalled being informed that the lesion could be benign (79.3%). Discussion of RMB was recalled by 55.2% of respondents, whereas 29.3% reported no recollection of biopsy discussion. Overall decision regret was low, with a mean DRS of 13.8 (95% confidence interval [CI] 10.3–17.4), although 27.6% demonstrated clinically significant regret (DRS ≥ 25). Despite benign histology, 87.9% believed surgery had been the correct decision and only 29.3% would retrospectively have preferred RMB before surgery. Lower regret scores were observed in patients who recalled detailed RMB discussion and reported higher perceived quality of preoperative counselling.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Most patients undergoing RALPN for benign small renal masses reported low decision regret despite ultimately benign pathology. Although over one-quarter of patients demonstrated clinically significant regret, the majority remained satisfied with their treatment decision and believed surgery had been the correct choice. Comprehensive counselling regarding diagnostic uncertainty and the potential role of renal m","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"7 10","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.70289","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BJUI compassPub Date : 2026-10-16DOI: 10.1002/bco2.70297
Ibrahim A. Khalil, Fatima A. Al-Jassim, Yaser M. Ata, Humam Emad Rajha, Abdulhamed Mansour, Ibrahim Al-Emadi, Khalid Al-Jalham, Khalid Al Rumaihi
{"title":"En bloc stapler versus separate clip ligation for renal hilar control during robotic-assisted nephrectomy: A retrospective comparative cohort study","authors":"Ibrahim A. Khalil, Fatima A. Al-Jassim, Yaser M. Ata, Humam Emad Rajha, Abdulhamed Mansour, Ibrahim Al-Emadi, Khalid Al-Jalham, Khalid Al Rumaihi","doi":"10.1002/bco2.70297","DOIUrl":"https://doi.org/10.1002/bco2.70297","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This study aimed to compare en bloc endovascular stapler ligation (ENBLOC) with separate clip ligation (CLIPS) for renal hilar control during robotic-assisted nephrectomy, with emphasis on perioperative safety.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patients and methods</h3>\u0000 \u0000 <p>This single-centre retrospective cohort included 193 consecutive adults undergoing robotic-assisted radical nephrectomy, simple nephrectomy or nephroureterectomy between January 2018 and December 2025. Patients were classified as CLIPS (<i>n</i> = 66) or ENBLOC (<i>n</i> = 127). Primary safety outcomes were intraoperative complications, postoperative complications and postoperative arteriovenous fistula (AVF) formation. Operative, renal functional and oncological outcomes were secondary or exploratory. Procedure-specific subgroup analyses were also performed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Baseline characteristics were largely comparable, except for ASA III–IV status was more frequent in the CLIPS group (27.3% vs. 16.5%, <i>p</i> = 0.029). Operative time (206.5 vs. 218.0 min, <i>p</i> = 0.26), estimated blood loss (median 100 mL in both groups, <i>p</i> = 0.37) and transfusion rates (1.5% vs. 5.5%, <i>p</i> = 0.19) did not differ significantly. Intraoperative complications occurred in 3/66 (4.5%) CLIPS and 8/127 (6.3%) ENBLOC patients (OR 1.41, 95% CI 0.36–5.51; absolute risk difference 1.8 percentage points, 95% CI − 4.8 to 8.3; <i>p</i> = 0.752). Postoperative complications occurred in 5/66 (7.6%) and 9/127 (7.1%) patients, respectively (<i>p</i> = 0.91). No AVF was identified during follow-up. Exploratory subgroup analyses did not identify additional statistically significant between-group differences, although estimates were limited by small sample sizes and sparse events.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>En bloc stapler ligation was not associated with statistically significant differences in the evaluated safety outcomes compared with separate clip ligation. However, the observational design and limited number of events preclude conclusions regarding equivalence, and clinically relevant differences cannot be excluded.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"7 10","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.70297","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}